180 related articles for article (PubMed ID: 31252679)
1. Isoform-Specific Role of Akt in Oral Squamous Cell Carcinoma.
Roy NK; Monisha J; Padmavathi G; Lalhruaitluanga H; Kumar NS; Singh AK; Bordoloi D; Baruah MN; Ahmed GN; Longkumar I; Arfuso F; Kumar AP; Kunnumakkara AB
Biomolecules; 2019 Jun; 9(7):. PubMed ID: 31252679
[TBL] [Abstract][Full Text] [Related]
2. AKT2 is the predominant AKT isoform expressed in human skeletal muscle.
Matheny RW; Geddis AV; Abdalla MN; Leandry LA; Ford M; McClung HL; Pasiakos SM
Physiol Rep; 2018 Mar; 6(6):e13652. PubMed ID: 29595878
[TBL] [Abstract][Full Text] [Related]
3. Development and characterization of protein kinase B/AKT isoform-specific nanobodies.
Merckaert T; Zwaenepoel O; Gevaert K; Gettemans J
PLoS One; 2020; 15(10):e0240554. PubMed ID: 33045011
[TBL] [Abstract][Full Text] [Related]
4. Akt isoform-specific effects on thyroid cancer development and progression in a murine thyroid cancer model.
Saji M; Kim CS; Wang C; Zhang X; Khanal T; Coombes K; La Perle K; Cheng SY; Tsichlis PN; Ringel MD
Sci Rep; 2020 Oct; 10(1):18316. PubMed ID: 33110146
[TBL] [Abstract][Full Text] [Related]
5. Isoform-specific roles for AKT in affective behavior, spatial memory, and extinction related to psychiatric disorders.
Wong H; Levenga J; LaPlante L; Keller B; Cooper-Sansone A; Borski C; Milstead R; Ehringer M; Hoeffer C
Elife; 2020 Dec; 9():. PubMed ID: 33325370
[TBL] [Abstract][Full Text] [Related]
6. Defining the Akt1 interactome and its role in regulating the cell cycle.
Duggal S; Jailkhani N; Midha MK; Agrawal N; Rao KVS; Kumar A
Sci Rep; 2018 Jan; 8(1):1303. PubMed ID: 29358593
[TBL] [Abstract][Full Text] [Related]
7. Substrate preference of protein kinase B isoforms can vary depending on the cell line.
Palma MS; Perez SR; Husain A; Bhandari D
PLoS One; 2024; 19(3):e0298322. PubMed ID: 38502658
[TBL] [Abstract][Full Text] [Related]
8. Precision Targeting of
Liu X; Long MJC; Hopkins BD; Luo C; Wang L; Aye Y
ACS Cent Sci; 2020 Jun; 6(6):892-902. PubMed ID: 32607436
[TBL] [Abstract][Full Text] [Related]
9. Inflection of Akt/mTOR/STAT-3 cascade in TNF-α induced protein 8 mediated human lung carcinogenesis.
Bordoloi D; Banik K; Vikkurthi R; Thakur KK; Padmavathi G; Sailo BL; Girisa S; Chinnathambi A; Alahmadi TA; Alharbi SA; Buhrmann C; Shakibaei M; Kunnumakkara AB
Life Sci; 2020 Dec; 262():118475. PubMed ID: 32976884
[TBL] [Abstract][Full Text] [Related]
10. Rationalizing the therapeutic potential of apigenin against cancer.
Ahmed SA; Parama D; Daimari E; Girisa S; Banik K; Harsha C; Dutta U; Kunnumakkara AB
Life Sci; 2021 Feb; 267():118814. PubMed ID: 33333052
[TBL] [Abstract][Full Text] [Related]
11. Targeting AKT/mTOR in Oral Cancer: Mechanisms and Advances in Clinical Trials.
Harsha C; Banik K; Ang HL; Girisa S; Vikkurthi R; Parama D; Rana V; Shabnam B; Khatoon E; Kumar AP; Kunnumakkara AB
Int J Mol Sci; 2020 May; 21(9):. PubMed ID: 32384682
[TBL] [Abstract][Full Text] [Related]
12.
Tomic U; Nikolic N; Carkic J; Mihailovic D; Jelovac D; Milasin J; Pucar A
Pathogens; 2023 Sep; 12(10):. PubMed ID: 37887710
[TBL] [Abstract][Full Text] [Related]
13. The Role of IL-17 in the Pathogenesis of Oral Squamous Cell Carcinoma.
Ladjevac N; Milovanovic M; Jevtovic A; Arsenijevic D; Stojanovic B; Dimitrijevic Stojanovic M; Stojanovic B; Arsenijevic N; Arsenijevic A; Milovanovic J
Int J Mol Sci; 2023 Jun; 24(12):. PubMed ID: 37373022
[TBL] [Abstract][Full Text] [Related]
14. Significance and expression of p-Akt in oral squamous cell carcinoma.
Hindy SA
J Oral Maxillofac Pathol; 2022; 26(4):602. PubMed ID: 37082060
[TBL] [Abstract][Full Text] [Related]
15. Upregulation of KHDC1L promotes the proliferation and inhibits apoptosis in head and neck squamous cell carcinoma.
Zhang Q; Luo S; Luo Y; Huang Y; Wang Z; Xie X
Epigenetics; 2023 Dec; 18(1):2175168. PubMed ID: 36734243
[TBL] [Abstract][Full Text] [Related]
16. The promising potential of piperlongumine as an emerging therapeutics for cancer.
Parama D; Rana V; Girisa S; Verma E; Daimary UD; Thakur KK; Kumar A; Kunnumakkara AB
Explor Target Antitumor Ther; 2021; 2(4):323-354. PubMed ID: 36046754
[TBL] [Abstract][Full Text] [Related]
17. Potential of guggulsterone, a farnesoid X receptor antagonist, in the prevention and treatment of cancer.
Girisa S; Parama D; Harsha C; Banik K; Kunnumakkara AB
Explor Target Antitumor Ther; 2020; 1(5):313-342. PubMed ID: 36046484
[TBL] [Abstract][Full Text] [Related]
18. The multifaceted role of STAT3 pathway and its implication as a potential therapeutic target in oral cancer.
Khatoon E; Hegde M; Kumar A; Daimary UD; Sethi G; Bishayee A; Kunnumakkara AB
Arch Pharm Res; 2022 Aug; 45(8):507-534. PubMed ID: 35987863
[TBL] [Abstract][Full Text] [Related]
19. Computational simulations of identified marine-derived natural bioactive compounds as potential inhibitors of oral cancer.
Natarajan PM; Umapathy VR; Murali A; Swamikannu B
Future Sci OA; 2022 Mar; 8(3):FSO782. PubMed ID: 35251696
[TBL] [Abstract][Full Text] [Related]
20. Emerging roles of cardamonin, a multitargeted nutraceutical in the prevention and treatment of chronic diseases.
Daimary UD; Parama D; Rana V; Banik K; Kumar A; Harsha C; Kunnumakkara AB
Curr Res Pharmacol Drug Discov; 2021; 2():100008. PubMed ID: 34909644
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
